Preemptive analgesia I: Physiological pathways and pharmacological modalities

Canadian Journal of Anesthesia

Volumn 48, Issue 10, 2001, Pages 1000-1010

  Kelly, Dermot J ^a   Ahmad, Mahmood ^b   Brull, Sorin J ^b  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; BRADYKININ ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CLONIDINE; DELTA OPIATE RECEPTOR AGONIST; DEXMEDETOMIDINE; DEXTROMETHORPHAN; GLUCOCORTICOID; KAPPA OPIATE RECEPTOR AGONIST; KETAMINE; LOCAL ANESTHETIC AGENT; MORPHINE; MU OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NITRIC OXIDE SYNTHASE INHIBITOR; NOCICEPTIN RECEPTOR; NOCICEPTIN RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROSTAGLANDIN SYNTHASE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANALGESIA; ANESTHESIA INDUCTION; ARTICLE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; MEDICAL LITERATURE; MEDLINE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PATIENT CARE; PERIPHERAL NERVOUS SYSTEM; POSTOPERATIVE PERIOD; PREMEDICATION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REGIONAL ANESTHESIA; SENSITIZATION; SIDE EFFECT; SURGICAL INJURY; TIME; TREATMENT INDICATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANALGESIA; ANALGESICS, OPIOID; ANESTHESIA, CONDUCTION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EFFERENT PATHWAYS; HUMANS; PAIN; PAIN, POSTOPERATIVE; PERCEPTION; PREMEDICATION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0035691566     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016591     Document Type: Article

References (104)

1. General vs. regional anesthesia
2. Physiological properties of unmyelinated fiber projection to the spinal cord
3. 2-induced activation and sensitization of articular mechanonociceptors
4. Peptides and the primary afferent nociceptor
5. Contributions of arachidonic acid derivatives and substance P to the sensitization of cutaneous nociceptors
6. Kinins and kinin receptors in the nervous system
7. Inflammatory mediators of pain
8. Recent topics in the management of pain: Development of the concept of preemptive analgesia
9. Neurogenic inflammation
10. Psychophysical studies of the itch sensation and itchy skin ("alloknesis") produced by intracutaneous injection of histamine
11. Nociceptive peripheral neurons: Cellular properties
12. Further studies on carrageenan-induced pleurisy in rats
13. Pharmacological analysis of the acute inflammatory process induced in the rat's paw by local injection of carrageenin and by heating
14. Nitric oxide evokes pain in humans on intracutaneous injection
15. The dorsal horn
16. Actions of substance P on rat spinal dorsal horn neurones
17. Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat
18. Intraspinal release of immunoreactive calcitonin gene-related peptide during development of inflammation in the joint in vivo - A study with antibody microprobes in cat and rat
19. Selective excitation of neurons in the mammalian spinal dorsal horn by aspartate and glutamate in vitro: Correlation with location and excitatory input
20. The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro
21. Effects of iontophoretically released amino acids and amines on primate spinothalamic tract cells
22. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P
23. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence
24. C-fos induction in the spinal cord following noxious stimulation: Prevention by opiates but not by NMDA antagonists
25. Ascending somatosensory systems
26. Sensory, motivational, and central control determinants of pain. A new conceptual model
27. Role of the reticular formation in responses to noxious stimulation
28. Trigeminothalamic neurons in nucleus caudalis responsive to tactile, thermal, and nociceptive stimulation of monkey's face
29. Brainstem excitatory amino acid receptors in nociception: Microinjection mapping and pharmacological characterization of glutamate-sensitive sites in the brainstem associated with algogenic behavior
30. Halothane-induced changes in neuronal activity of cells of the nucleus reticularis gigantocellularis of the cat
31. Spinal trigeminal neurons excited by noxious and thermal stimuli
32. Effects of ketamine on nociceptive cells in the medial medullary reticular formation of the cat
33. Fentanyl and alfentanil suppress brainstem pain transmission
34. Peripheral and spinal mechanisms of nociception
35. The pharmacology of segmental transmission in the spinal cord
36. Neurotransmitters in nociceptive modulatory circuits
37. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists
38. Spinal cord pharmacology of pain
39. Antinociceptive and 'neurotoxic' actions of somatostatin in rat spinal cord after intrathecal administration
40. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization
41. Experimental evidence on the nature of cutaneous hyperalgesia
42. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
43. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin
44. Neurogenic hyperalgesia: The search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia
45. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
46. Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons
47. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans
48. Pain pathways and transmission
49. Non-steroidal anti-inflammatory drugs: Rationale for use in severe postoperative pain
50. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat
51. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects
52. Pre- and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord
53. An opiate-receptor gene family reunion
54. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn
55. Outflow of endogenous aspartate and glutamate from the rat spinal dorsal horn in vitro by activation of low- And high-threshold primary afferent fibers. Modulation by mu-opioids
56. Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibres projecting in the rat cervical cord
57. A cure for wind up: NMDA receptor antagonists as potential analgesics
58. Mechanisms of the analgesic actions of opiates and opioids
59. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2, 5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N, N-diethylbenzamide (SNC 80): A highly selective, receptor agonist
60. Opioid receptors and their relevance to anaesthesia
61. K-opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat
62. K-opioid receptors and analgesia
63. Involvement of the mu-opiate receptor in peripheral analgesia
64. K- And delta-opioids block sympathetically dependent hyperalgesia
65. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation
66. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat
67. Pharmacology of chronic pain
68. Activity-dependent neuronal plasticity following tissue injury and inflammation
69. Central hyperexcitability triggered by noxious inputs
70. Central neural mechanisms of normal and abnormal pain states
71. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat
72. Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat
73. Spinal local anaesthetic actions on afferent evoked responses and wind-up of nociceptive neurones in the rat spinal cord: Combination with morphine produces marked potentiation of antinociception
74. The site and the mode of analgesic actions exerted by clonidine in monkeys
75. A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions
76. Intravenous or epidural clonidine for intra- and post-operative analgesia
77. Interaction between opiate subtype and alpha-2 adrenergic agonists in suppression of noxiously evoked activity of WDR neurons in the spinal dorsal horn
78. Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord
79. The addition of epinephrine enhances postoperative analgesia by intrathecal morphine
80. Development of tolerance to the analgesic effect of clonidine in rats. Cross-tolerance to morphine
81. Spinal infusion of opiate and alpha-2 agonists in rats: Tolerance and cross-tolerance studies
82. Clonidine blocks acute opiate-withdrawal symptoms
83. Interactions between noradrenergic and cholinergic mechanisms involved in spinal nociceptive processing
84. A cholinergic interaction in alpha 2 adrenoceptor-mediated antinociception in sheep
85. Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced inflammation
86. Cholecystokinin and morphine analgesia: Variations on a theme
87. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord
88. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Entinociceptive and cardiovascular effects
89. A receptors and excitatory amino acids in the mouse spinal cord
90. Bradykinin receptor antagonists
91. Bradykinin and inflammatory pain
92. Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord
93. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system
94. Postoperative analgesia from intrathecal neostigmine in sheep
95. Intrathecal amitriptyline. Antinociceptive interactions with intravenous morphine and intrathecal clonidine, neostigmine, and carbamylcholine in rats
96. Intrathecal acetyl cholinesterase inhibitors produce analgesia that is synergistic with morphine and clonidine in rats
97. Studies on the development of tolerance and potential spinal neurotoxicity after chronic intrathecal carbachol-antinociception in the rat
98. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat
99. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: A common mechanism of action?
100. Classification of adenosine receptors mediating antinociception in the rat spinal cord
101. 2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord